Astera Labs, Inc. ALAB
We take great care to ensure that the data presented and summarized in this overview for Astera Labs, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in ALAB
Top Purchases
Top Sells
About ALAB
Insider Transactions at ALAB
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 11
2024
|
Michael Truett Tate Chief Financial Officer |
SELL
Bona fide gift
|
Indirect |
50,000
-1.19%
|
-
|
|
Dec 04
2024
|
Michael Truett Tate Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
16,000
-0.19%
|
$1,888,000
$118.08 P/Share
|
|
Dec 04
2024
|
Manuel Alba Director |
SELL
Open market or private sale
|
Indirect |
11,000
-0.15%
|
$1,298,000
$118.18 P/Share
|
|
Dec 03
2024
|
Manuel Alba Director |
SELL
Open market or private sale
|
Indirect |
63,000
-0.24%
|
$6,993,000
$111.57 P/Share
|
|
Dec 03
2024
|
Michael Truett Tate Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
167,000
-0.91%
|
$18,537,000
$111.86 P/Share
|
|
Dec 02
2024
|
Manuel Alba Director |
SELL
Open market or private sale
|
Indirect |
63,000
-0.61%
|
$6,426,000
$102.99 P/Share
|
|
Dec 02
2024
|
Michael Truett Tate Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
167,000
-2.44%
|
$17,201,000
$103.04 P/Share
|
|
Nov 29
2024
|
Jitendra Mohan Chief Executive Officer |
SELL
Bona fide gift
|
Indirect |
12,600
-0.28%
|
-
|
|
Nov 27
2024
|
Michael E. Hurlston Director |
SELL
Open market or private sale
|
Direct |
67,453
-6.21%
|
$6,812,753
$101.06 P/Share
|
|
Nov 26
2024
|
Stefan A Dyckerhoff |
SELL
Open market or private sale
|
Direct |
7,814
-6.03%
|
$836,098
$107.17 P/Share
|
|
Nov 26
2024
|
Stefan A Dyckerhoff |
SELL
Open market or private sale
|
Indirect |
7,815
-2.1%
|
$836,205
$107.17 P/Share
|
|
Nov 25
2024
|
Jitendra Mohan Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
173,366
-3.28%
|
$19,070,260
$110.12 P/Share
|
|
Nov 22
2024
|
Stefan A Dyckerhoff |
SELL
Open market or private sale
|
Indirect |
30,000
-6.64%
|
$3,150,000
$105.89 P/Share
|
|
Nov 21
2024
|
Jitendra Mohan Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
171,064
-3.12%
|
$17,619,592
$103.53 P/Share
|
|
Nov 19
2024
|
Stefan A Dyckerhoff |
SELL
Open market or private sale
|
Indirect |
6,148
-100.0%
|
$584,060
$95.3 P/Share
|
|
Nov 18
2024
|
Philip Mazzara General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
2,513
-1.0%
|
$226,170
$90.81 P/Share
|
|
Nov 18
2024
|
Michael Truett Tate Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,398
-2.52%
|
$665,820
$90.81 P/Share
|
|
Nov 18
2024
|
Stefan A Dyckerhoff |
SELL
Open market or private sale
|
Indirect |
197,297
-96.98%
|
$17,756,730
$90.51 P/Share
|
|
Nov 15
2024
|
Jack R Lazar Director |
SELL
Open market or private sale
|
Direct |
12,500
-2.39%
|
$1,087,500
$87.03 P/Share
|
|
Nov 14
2024
|
Philip Mazzara General Counsel and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
694
+0.28%
|
$20,820
$30.6 P/Share
|
Last 12 Months Summary
Buy / Acquisition
46.7M
Shares
From
16
Insiders
| Open market or private purchase | 36.7K shares |
|---|---|
| Grant, award, or other acquisition | 5.64M shares |
| Exercise of conversion of derivative security | 40K shares |
| Conversion of derivative security | 39.9M shares |
| Bona fide gift | 1.03M shares |
| Other acquisition or disposition | 23.8K shares |
Sell / Disposition
10.1M
Shares
From
15
Insiders
| Open market or private sale | 3.34M shares |
|---|---|
| Other acquisition or disposition | 5.61M shares |
| Payment of exercise price or tax liability | 32.8K shares |
| Bona fide gift | 1.1M shares |